Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients

Clinical trial NCT07242547 · RECRUITING

Trial details

NCT number: NCT07242547
Sponsor: Fundación GECP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Limited-stage Small-cell Lung Cancer Carcinoma, Small Cell Lung Respiratory Tract Neoplasms Thoracic Neoplasms

Start date: 2026-05-20
Primary completion: 2030-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.